Gene Transfer to the Nigrostriatal System by Hybrid Herpes Simplex Virus/Adeno-Associated Virus Amplicon Vectors
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
To improve gene transfer to CNS neurons, critical elements of herpes simplex virus 1 (HSV-1) amplicons and recombinant adeno-associated virus (AAV) vectors were combined to construct a hybrid amplicon vector, and then packaged via a helper virus-free system. We tested the HSV/AAV hybrid amplicon vectors for transduction efficiency and stability of transgene expression (green fluorescent protein) in primary neuronal cultures from rat fetal ventral mesencephalon, in comparison with traditional HSV amplicon, AAV, or adenovirus (Ad) vectors at the same multiplicity of infection. The HSA/AAV hybrid vectors transduced the highest number of primary neurons in culture 2 days after infection. As compared with all other vectors tested, only hybrid vectors containing the AAV rep gene maintained the 2-day level of transgene expression over 12 days in culture. This rep-containing hybrid vector was then tested for efficiency and safety in the brain. One month after injection into adult rat striatum (1 x 10(6) transducing units injected), transgene expression was observed within the striatum (ranging from 564 to 8610 cells) and the substantia nigra (via retrograde transport, ranging from 130 to 809 neurons). The HSV/AAV hybrid amplicon vectors transduced predominantly neurons within the striatum, and showed transduction efficacy similar to and in many cases higher than that of HSV amplicon vectors. No immune response was observed in the HSA/AAV hybrid vector-injected brains, as determined by immune markers specific for helper T lymphocytes, cytotoxic T lymphocytes, and microglia. This HSV/AAV hybrid system shows high transduction efficiency and stability in culture. The effective and safe transgene delivery into the nigrostriatal system illustrates its potential for therapeutic application for neurologic disorders, such as Parkinson and Huntington disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Estimation of nuclear population from microtome sections
Abercrombie, M. (1946) · The Anatomical Record · doi:10.1002/ar.1090940210 · Cited by 4,363
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381 · cited 4×
“The replication and packaging of AAV vectors previously required the presence of adenovirus (Ad) helper virus; however, one study has described an Ad-free method for producing recombinant AAV at high titers (Xiao et al ., 1998).”
InfluentialDevelopment of a self-inactivating lentivirus vector
Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196 · cited 3×
“…transfer to the CNS, each with its own advantages and limitations (Lawrence et al ., 1996; Bowers et al ., 1997; Davidson and Bohn, 1997; Verma and Somia, 1997; Fraefel et al ., 1998; Man-del et al ., 1998; Miyoshi et al ., 1998; Oligino et al ., 1998; Ren-dahl et al ., 1998; Xiao et al ., 1998).”
Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus
Sodeik, B., Ebersold, M. W., & Helenius, A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.5.1007 · Cited by 687
Duan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K. J., & Engelhardt, J. F. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8568-8577.1998 · Cited by 522 · cited 2×
“…kb of foreign DNA inserts (Muzyczka, 1992), and contains AAV inverted terminal repeats (ITRs) that carry signals promoting extrachromosomal replication and integration of transgenes at multiple sites in the genome (Xiao et al ., 1997; Yang et al ., 1997; Duan et al ., 1998; Wu et al ., 1998).”
Bilang-Bleuel, A., Revah, F., Colin, P., Locquet, I., Robert, J.-J., Mallet, J., & Horellou, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8818 · Cited by 297
Cited by
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
“Site-specific integration of AAV inverted terminal repeat (ITR)-flanked transgenes has been shown in cell culture from adenovirus vectors and from herpes-virus amplicon vectors that express the AAV Rep68/78 protein”
BackgroundFGF-2 regulation of neurogenesis in adult hippocampus after brain injury
Yoshimura, S., Takagi, Y., Harada, J., Teramoto, T., Thomas, S. S., Waeber, C., Bakowska, J. C., Breakefield, X. O., & Moskowitz, M. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101034998 · Cited by 455
Self-citationMazarakis, N. D. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.19.2109 · Cited by 426
Current approaches to enhance CNS delivery of drugs across the brain barriers
Lu, C.-T., Zhao, Y.-Z., Wong, H. L., Cai, J., Peng, L., & Tian, X.-Q. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s61288 · Cited by 350
Viral vectors for gene delivery to the nervous system
Davidson, B. L., & Breakefield, X. O. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1104 · Cited by 321
Self-citation
Metadata
- Authors
- Costantini, L. C., Jacoby, Wang, S., Fraefel, C., Breakefield, X. O., & Isacson, O.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1999-10-10
- Volume
- 10
- Issue
- 15
- Pages
- 2481-2494
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W1995849432
- Cited by
- 95
- References
- 8
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene Transfer to the Nigrostriatal System by Hybrid Herpes Simplex Virus/Adeno-Associated Virus Amplicon Vectors. https://app.cochat.ai/papers/10.1089/10430349950016825
- The paper
- Costantini, L. C., Jacoby, Wang, S., Fraefel, C., Breakefield, X. O., & Isacson, O. (1999). Gene Transfer to the Nigrostriatal System by Hybrid Herpes Simplex Virus/Adeno-Associated Virus Amplicon Vectors. Human Gene Therapy. https://doi.org/10.1089/10430349950016825
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.